DISCLAIMER: This content is NOT being updated and is only current as of the publication date.
IMPORTANT ATHLETE INFORMATION:
The World Anti-Doping Agency (WADA) has published the updated 2017 WADA Prohibited List, which goes into effect on January 1, 2017. Athletes and support personnel, including coaches, parents, physicians, trainers, and dieticians, should take the time to review the updated WADA Prohibited List to understand how specific changes may impact them. The Prohibited List is divided into nine (9) categories of prohibited substances and three (3) categories of prohibited methods.
For more information on the prohibited status of an ingredient or medication, visit GlobalDRO.com, an easy-to-use and trusted resource available 24/7/365 to athletes and support personnel in Australia, Canada, Japan, the United Kingdom, and the United States. Check now and check often!
In addition to reviewing the updated WADA Prohibited List and using Global DRO, it’s worth exploring some of the highlighted changes for 2017 below:
Substances and Methods Prohibited At All Times (In and Out-of-Competition)
S1: Anabolic Agents
- New Example of Prohibited Substance Added: 5α-androst-2-ene-17-one, commonly known as “Delta-2” or 2-androstenone, was added as an example of metabolite of DHEA, more recently found in dietary supplements.
S2: Peptide Hormones, Growth Factors, Related Substances and Mimetics
- Prohibited Substance Added: GATA inhibitors (e.g., K-11706) and Transforming Growth Factor- β (TGF-β) inhibitors (e.g., sotatercept, luspatercept) were added.
- New Examples of Prohibited Substances Added: Molidustat was added as another example of an HIF stabilizer.
- Clarification on Cobalt: It is reiterated that vitamin B12, which contains cobalt, is not prohibited.
S3: Beta-2 Agonists
- New Examples of Prohibited Substances Added: Examples of selective and non-selective beta-2-agonists were added (fenoterol, formoterol, higenamine, indacaterol, olodaterol, procaterol, reproterol, salbutamol, salmeterol, terbutaline, vilanterol).
- Higenamine is Prohibited: Higenamine is documented to be a constituent of the plant Tinospora crispa, which can be found in some dietary supplements and is a non-selective beta-2-agonist.
- Clarification on Salbutamol: Dosing parameters of salbutamol were refined to make it clear that the full 24-hour dose should not be administered at one time; For inhaled salbutamol: maximum 1600 micrograms over 24 hours, not to exceed 800 micrograms every 12 hours.
- Clarification on Salmeterol: The maximum dosage for salmeterol was stated according to the manufacturers’ recommendations; For inhaled salmeterol: maximum 200 micrograms over 24 hours.
S4: Hormone and Metabolic Modulators
- Example of Prohibited Substance Added: Androsta-3,5-diene-7,17-dione (arimistane) was added as a new example of aromatase inhibitor.
M1: Manipulations of Blood and Blood Components
- Clarification on supplemental oxygen use: Supplemental oxygen administered by inhalation, but not intravenously, is permitted. To clarify this, M1.2 now reads “excluding supplemental oxygen by inhalation.”
Substances and Methods Prohibited In-Competition
- Example of Prohibited Substance Added: Lisdexamfetamine was added as an example to S6.a; it is an inactive pro-drug of amfetamine.
- Clarification on Phenylethylamine: Regular food consumption will not yield sufficient levels of phenylethylamine to result in an Adverse Analytical Finding.
- Prohibited Substance Added: Nicomorphine was added. It is an opioid analgesic drug, which is converted to morphine following administration.
Athletes, like all people, may have medically justified illnesses or conditions that require them to take a particular medication/substance, or undergo certain procedures/methods. If the substance or method appears on the WADA Prohibited List, athletes may be granted a Therapeutic Use Exemption (TUE), which gives them permission to take a substance or use a method. TUEs are only granted if the athlete provides the medical documentation necessary for an independent TUE Committee to determine that a substance or method is medically necessary to return the athlete to a normal level of health. Learn more here.
For additional assistance, contact USADA’s Drug Reference Team at email@example.com or by phone at 719.785.2000 (option 2) to speak with an expert about your questions or concerns.
Thank you for competing clean and being a voice for clean athletes!